Product Information

METHYLPHENIDATE 30 MG/9 HR PATCH is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $6.6115 per EA under NDC 00378826393. Its NADAC has been published 195 times since Feb 22, 2023.

FDA first approved this application on Mar 14, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE 30 MG/9 HR PATCH

Methylphenidate
$6.6115per EA
DEA Schedule CII

Strength

3.3 mg/h

NDC

00378826393

Classification

Generic

Dosage Form

PATCH

Route

TRANSDERMAL

Effective Date

10/21/2026

Active Ingredients

METHYLPHENIDATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206497

FDA Approved

3/14/2022

TE Code

AB

On Market Since

6/27/2022

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE 30 MG/9 HR PATCH has been published 195 times since Feb 22, 2023, and over the history we have for it it has declined 49.1%. The table below summarizes its recorded NADAC range and movement.

Current price$6.6115 per EA
All-time high$12.9826 (May 10, 2023)
All-time low$6.6115 (Oct 21, 2026)
52-week high$9.7948
52-week low$6.6115
Median price$9.6026
Average price$10.2977
Largest weekly change-9.0% (Jul 17, 2024)
Weeks tracked195
Tracking sinceFeb 22, 2023

Price History

1W

0.0%

1M

-8.8%

3M

-16.2%

6M

-24.2%

1Y

-30.3%

3Y

-48.4%

5Y

N/A

All

-49.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methylphenidate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE 30 MG/9 HR PATCH?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 30 MG/9 HR PATCH, manufactured by Mylan Pharmaceuticals Inc., is $6.6115 per EA (NDC 00378826393), effective Nov 11, 2026.

How has the price of METHYLPHENIDATE 30 MG/9 HR PATCH changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE 30 MG/9 HR PATCH has declined 49.1%. It has been tracked across 195 weekly CMS publications since Feb 22, 2023.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 30 MG/9 HR PATCH?

Since Feb 22, 2023, the NADAC for METHYLPHENIDATE 30 MG/9 HR PATCH has ranged from a low of $6.6115 (Oct 21, 2026) to a high of $12.9826 (May 10, 2023), with a median of $9.6026 per EA.

Are there cheaper alternatives to METHYLPHENIDATE 30 MG/9 HR PATCH?

No other NADAC-published product currently shares the active ingredient and strength of METHYLPHENIDATE 30 MG/9 HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures METHYLPHENIDATE 30 MG/9 HR PATCH?

METHYLPHENIDATE 30 MG/9 HR PATCH (NDC 00378826393) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.